Highlights Binding strategic alliance with KBR (NYSE: KBR), a world-leading engineering group and global technology licensor set to supercharge Hazer’s commercialisation strategyHazer is KBR’s exclusive partner for marketing and licensing of methane pyrolysis technologyClear revenue visibility targeting multiple license deals within 6 years, materially derisking Hazer’s businessplan Capital-lite licensing model maintained; KBR A$3million work program contribution preserves Hazer’s robust funding positionStr ...

– Fast Track Designation highlights potential of ATH434 to address high unmet need for individuals with MSA – MELBOURNE, Australia and SAN FRANCISCO, May 05, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for ATH434 for the treatment of Multiple S ...

LOUISVILLE, Ky., May 05, 2025 (GLOBE NEWSWIRE) -- Creative Realities, Inc. ("Creative Realities," "CRI," or the "Company") (NASDAQ: CREX), a leading provider of digital signage and media solutions, announced today that it will release its financial results for the three months ended March 31, 2025 before the market open on Wednesday, May 14, 2025. A conference call to review the results is scheduled for Wednesday, May 14, 2025, at 9:00 am Eastern Time, which will include prepared remarks and materials from ...

WAYNE, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella or “the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no U.S. Food and Drug Administration (FDA)-approved therapies, announced today that the Company will ring the opening bell at the Nasdaq Stock Market (Nasdaq) on Monday, May 12, 2025 in New York City. Wes ...

Coralville, IA, May 05, 2025 (GLOBE NEWSWIRE) -- SunHydrogen, Inc. (OTC: HYSR), the developer of innovative technologies for producing renewable hydrogen using sunlight and water, today announced that it has contracted The Process Group, LLC (TPG Engineers) for front-end engineering design of a >25-square-meter proof-of-concept hydrogen production pilot plant. Building on SunHydrogen’s earlier multi-module 1m2 demonstration, this pilot facility will deploy the company’s proprietary photoelectrochemical (PE ...

TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”) has filed on SEDAR+ a technical report prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101”) on the Mercur Project (“Mercur” or the “Project”), titled “Preliminary Economic Assessment NI 43-101 Technical Report on the Mercur Gold Project, Tooele & Utah Counties, Utah, USA” (the “Technical Report”). The Technical Report supports ...

The Annual General Meeting of Shareholders (the “AGM”) of Orrön Energy AB (“Orrön Energy” or the “Company”) was held today, 5 May 2025. The Company’s and the Group’s income statements and balance sheets for the financial year 2024, were adopted and the members of the Board of Directors and the Chief Executive Officer were discharged from liability for the financial year 2024. The AGM resolved that no dividends should be paid for the financial year 2024 and that the distributable reserves are brought forward ...

Leading Food-Service and Commercial Refrigeration Distributor in Sunbelt MarketsMIAMI, May 05, 2025 (GLOBE NEWSWIRE) -- Watsco, Inc. (NYSE: WSO) announced that it has completed the acquisition of Southern Ice Equipment Distributors as well as two other transactions completed thus far in 2025. Terms of the transactions were not disclosed. Founded in 1984 and based in Lafayette, Louisiana, Southern Ice is a leading distributor of food-service and commercial refrigeration equipment, parts and supplies, includi ...

Drill-out of all high-grade Surebet lodes will be more easily and cheaply facilitated from underground vantages.Underground access to the Bonanza Zone will enable geological confirmation of this important high-grade lode and potentially enable bulk sampling.Goliath looks forward to mobilizing shortly for its aggressive 2025 drill campaign. TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Goliath Resources Limited (TSX-V: GOT) (OTCQB: GOTRF) (FSE: B4IF) (the “Company” or “Goliath”) is pleased to announce world reno ...

Core Viewpoint - Quantum BioPharma Ltd. has filed an amended complaint alleging market manipulation by several banks, seeking damages exceeding $700 million USD due to the alleged manipulation of its stock price through "spoofing" techniques from January 2020 to August 2024 [1][2][3]. Group 1: Legal Proceedings - The amended complaint was filed on May 1, 2025, in response to a Motion to Dismiss from the banks [1]. - The lawsuit claims that CIBC World Markets and RBC Dominion Securities, among others, violated the Securities Exchange Act of 1934 [1][2]. - The law firms Christian Attar and Freedman Normand Friedland LLP are representing the company on a contingency basis, alleviating financial pressure for legal costs [2]. Group 2: Allegations of Market Manipulation - The complaint alleges that the defendants engaged in "spoofing" techniques that artificially depressed Quantum BioPharma's stock price [2]. - The company asserts that the stock was trading over $460 USD per share in January 2020, with a market capitalization nearing $1 billion USD [3]. - Quantum BioPharma believes that additional banks and brokers may also be involved in the alleged manipulation but will not disclose their names until more evidence is gathered [3]. Group 3: Company Overview - Quantum BioPharma is focused on developing innovative biopharmaceutical solutions for neurodegenerative and metabolic disorders [7]. - The company is advancing its lead compound, Lucid-MS, which aims to prevent and reverse myelin degradation associated with multiple sclerosis [8]. - Quantum BioPharma retains a 22.95% ownership stake in Celly Nutrition Corp., which includes a royalty agreement on sales from its product unbuzzd™ [8].